• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    7/17/24 6:03:31 AM ET
    $ADVM
    $APVO
    $ASML
    $ASST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.

    Bloom Energy said it entered into a partnership to deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center in Illinois.

    Bloom Energy shares jumped 12.1% to $16.90 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shimmick Corporation (NASDAQ:SHIM) gained 53% to $3.09 in pre-market trading after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares rose 39.3% to $0.46 in pre-market trading after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares rose 26.1% to $3.58 in pre-market trading after declining around 14% on Tuesday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) rose 16.1% to $0.2916 in pre-market trading. Conduit Pharmaceuticals shares gained around 5% on Tuesday after the company announced it received patent approval for its lead asset targeting autoimmune diseases..
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares gained 15.5% to $10.31 in pre-market trading. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • GitLab Inc. (NASDAQ:GTLB) gained 13.9% to $57.71 in pre-market trading after Reuters reported that the company is exploring a sale.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 12.6% to $1.77 in pre-market trading.
    • Immersion Corporation (NASDAQ:IMMR) shares surged 12.4% to $13.69 in pre-market trading after gaining over 5% on Tuesday.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares gained 7.7% to $0.21 in pre-market trading.

    Losers

    • Cineverse Corp (NASDAQ:CNVS) shares fell 15.6% to $0.75 in pre-market trading.
    • Logistic Properties of the Americas (NYSE:LPA) shares fell 15.2% to $22.04 in pre-market trading after jumping 69% on Tuesday.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 15.2% to $1.28 in pre-market trading after jumping 41% on Tuesday.
    • Five Below, Inc. (NASDAQ:FIVE) shares declined 14.7% to $87.00 in pre-market trading after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 11% to $0.3642 in pre-market trading.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares fell 9.2% to $2.17 in pre-market trading. Silo Pharma shares jumped 123% on Tuesday after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 8.7% to $0.48 in pre-market trading. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Cerus Corporation (NASDAQ:CERS) fell 8.4% to $2.19 in pre-market trading. On July 2, Cerus announced the appointment of Dean Gregory to its Board of Directors.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 6.8% to $1.77 in pre-market trading after gaining over 9% on Tuesday.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 6.8% to $995.90 in pre-market trading. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens’
    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APVO
    $ASML
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    GitLab Inc.
    $GTLB
    4/16/2026$24.00Buy → Neutral
    UBS
    Bloom Energy Corporation
    $BE
    4/14/2026$187.00Underperform → Hold
    Jefferies
    Strive Inc.
    $ASST
    4/10/2026$26.00Buy
    TD Cowen
    GitLab Inc.
    $GTLB
    4/9/2026Buy → Neutral
    Guggenheim
    GitLab Inc.
    $GTLB
    3/23/2026Outperform → Underperform
    William Blair
    Five Below Inc.
    $FIVE
    3/19/2026Mkt Perform → Outperform
    William Blair
    Five Below Inc.
    $FIVE
    3/19/2026$240.00 → $260.00Outperform
    Telsey Advisory Group
    Shimmick Corporation
    $SHIM
    3/13/2026$5.00Neutral → Buy
    Roth Capital
    More analyst ratings

    $ADVM
    $APVO
    $ASML
    $ASST
    SEC Filings

    View All

    GitLab Inc. filed SEC Form 8-K: Leadership Update

    8-K - Gitlab Inc. (0001653482) (Filer)

    4/16/26 4:31:13 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    SEC Form 424B3 filed by Silo Pharma Inc.

    424B3 - Silo Pharma, Inc. (0001514183) (Filer)

    4/16/26 4:15:31 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    SEC Form EFFECT filed by Silo Pharma Inc.

    EFFECT - Silo Pharma, Inc. (0001514183) (Filer)

    4/16/26 12:15:03 AM ET
    $SILO
    Apparel
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Soderberg Shawn Marie

    4 - Bloom Energy Corp (0001664703) (Issuer)

    4/16/26 7:06:19 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    SEC Form 4 filed by Chitoori Satish

    4 - Bloom Energy Corp (0001664703) (Issuer)

    4/16/26 7:04:49 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    SEC Form 4 filed by Sijbrandij Sytse

    4 - Gitlab Inc. (0001653482) (Issuer)

    4/16/26 5:30:59 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GitLab downgraded by UBS with a new price target

    UBS downgraded GitLab from Buy to Neutral and set a new price target of $24.00

    4/16/26 8:00:58 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Bloom Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Bloom Energy from Underperform to Hold and set a new price target of $187.00

    4/14/26 1:08:30 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    TD Cowen initiated coverage on Strive with a new price target

    TD Cowen initiated coverage of Strive with a rating of Buy and set a new price target of $26.00

    4/10/26 8:35:32 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Pham Benjamin bought $115,095 worth of shares (14,114 units at $8.15) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/19/26 8:00:23 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Pres Tech/Chief Product Off Huidor Mark Antonio bought $75,000 worth of shares (37,500 units at $2.00), increasing direct ownership by 25% to 190,061 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:57:19 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CFO Lindsey Mark Wayne bought $70,000 worth of shares (35,000 units at $2.00), increasing direct ownership by 29% to 154,168 units (SEC Form 4)

    4 - Cineverse Corp. (0001173204) (Issuer)

    2/17/26 9:54:43 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GitLab Extends Agentic AI with New Automated Security Remediation, Pipeline Setup, and Delivery Analytics

    Agentic SAST Vulnerability Resolution is now generally available, automatically generating ready-to-merge code fixes and helping resolve vulnerabilities before they reach production. Two new agents in GitLab Duo Agent Platform allow teams to stand up a running CI pipeline in minutes and get fast visual answers from live software lifecycle data, eliminating two of the most persistent bottlenecks in software delivery. New subscription-level and per-user spending caps for GitLab Credits give organizations control over on-demand AI spend, enabling enterprise-wide rollout of GitLab Duo Agent Platform with predictable cost controls. All Remote — GitLab Inc., the intelligent orchestratio

    4/16/26 4:56:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

    Cerus Corporation (NASDAQ:CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A repl

    4/16/26 4:01:00 PM ET
    $CERS
    EDP Services
    Technology

    CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today provides a strategic update outlining its positioning as a multi-pathway value creation business spanning a pharmaceutical asset portfolio, proprietary solid-form intellectual property and artificial intelligence-driven indication discovery. The Company believes it is uniquely positioned through a combination of high-quality clinical assets, proprietary chemistry, and advanced data-driven capabilities to generate long-term shareholder value through a capital-efficient, out-licensing model. CDT continues to evaluate and advance its portfolio of asse

    4/16/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    Financials

    Live finance-specific insights

    View All

    Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

    Cerus Corporation (NASDAQ:CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company's financial results and provide a general business overview and outlook. To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event. A repl

    4/16/26 4:01:00 PM ET
    $CERS
    EDP Services
    Technology

    Bloom Energy to Announce First Quarter 2026 Financial Results on April 28, 2026

    Bloom Energy Corporation (NYSE:BE) today announced it will release its first quarter 2026 financial results on April 28, 2026, after market close. Bloom Energy's management will host a conference call at 2:00 p.m. Pacific Time (PT) / 5:00 p.m. Eastern Time (ET) on the same day to discuss these results. Q1 2026 Conference Call and Webcast Date: April 28, 2026 Time: 2 p.m. PT / 5 p.m. ET Duration: 60 minutes Live Dial in: 1.888.596.4144 (toll-free) | 1 .646.968.2525 Conference ID: 9681836 Live webcast: https://investor.bloomenergy.com/ A telephonic replay of the conference call will be accessible for one week following the call at: Dial in: 1 800 770 2030 (toll-free) | 1 (609) 800-9909 Pa

    4/15/26 9:00:00 AM ET
    $BE
    Industrial Machinery/Components
    Energy

    Strive Announces Increase to SATA Perpetual Preferred Stock Dividend Rate to 13.00% and Bitcoin Buy

    DALLAS, April 15, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST, SATA)) ("Strive" or the "Company") today announced a SATA dividend rate increase of 25 bps from 12.75% to 13.00% on its Variable Rate Series A Perpetual Preferred Stock (the "SATA Stock"), effective for monthly periods commencing on or after April 15, 2026.   The Company has declared a dividend of $1.0833 per share of SATA Stock, payable on May 15, 2026, to stockholders of record at the close of business on May 1, 2026. Strive expects the dividend to qualify as a non-taxable return of capital to the extent of a stockholder's tax basis in SATA Stock for U.S federal income tax purposes. Strive also announced the purchase

    4/15/26 8:00:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by CERo Therapeutics Holdings Inc.

    SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:06:55 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:01:41 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    Bloom Energy Appoints Simon Edwards as Chief Financial Officer

    Bloom Energy (NYSE:BE), a global leader in onsite power solutions, today announced the appointment of Simon Edwards as Chief Financial Officer, effective April 13, 2026. A seasoned finance executive with nearly two decades of experience scaling technology companies, Edwards brings a rare combination of operational rigor, systems leadership, and deep exposure to digital infrastructure that aligns with Bloom's strength, market focus and strategy – to be a solution for power availability as it becomes the defining constraint on the AI industry and its growth. Edwards joins Bloom from AI-inference leader Groq, where he most recently served as CEO after initially joining as CFO. At Groq, he le

    3/26/26 4:05:00 PM ET
    $BE
    Industrial Machinery/Components
    Energy

    Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

    William "Obi" Greenman to become Executive Chairman Leadership changes to take effect July 1, 2026 Cerus Corporation (NASDAQ:CERS) today announced that Vivek Jayaraman, Cerus' chief operating officer, will be promoted to president and chief executive officer, effective July 1, 2026. William "Obi" Greenman will become executive chairman of the board of directors. At the time of his appointment, Mr. Jayaraman will join the Board of Directors. "Following a thorough succession planning process, this transition represents a natural step as we prepare for the next phase of growth at Cerus," said Frank Witney, lead independent director on the Cerus Board of Directors. "The Board and I are de

    3/16/26 4:05:00 PM ET
    $CERS
    EDP Services
    Technology

    CERo Therapeutics Provides Shareholder Update

    Ongoing activities, including new engagement to relist on Nasdaq, new board member, continued advancement of Phase 1 trial into MDS patients, strategic engagement, and continued support from lead investor, underscore the Company's operational momentum SOUTH SAN FRANCISCO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism, provides an update through the letter to stockholders and stakeholders from CEO Chris Ehrlich: To our stockholders and stakeholders: Following our recent Form 8-K filing confirming receipt of convertible deb

    3/11/26 8:15:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care